Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | TLR8 | Q9NR97 | 5/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5116260 | 0.98 | MAPT (0.55) | MAPTHTR2AL3MBTL1TLR8KDM4E | |
| SCHEMBL8379349 | 0.98 | MAPT (0.55) | MAPTHTR2AL3MBTL1TLR8KDM4E | |
| SCHEMBL16267023 | 0.98 | MAPT (0.55) | MAPTHTR2AL3MBTL1TLR8KDM4E | |
| SCHEMBL16267503 | 0.98 | MAPT (0.55) | MAPTHTR2AL3MBTL1TLR8KDM4E | |
| SCHEMBL16267095 | 0.98 | MAPT (0.55) | MAPTHTR2AL3MBTL1TLR8KDM4E | |
| SCHEMBL7915017 | 0.94 | HTR2A (0.52) | MAPTHTR2AL3MBTL1TLR8KDM4E | |
| SCHEMBL7875750 | 0.89 | HTR2A (0.60) | MAPTHTR2AL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL7877797 | 0.87 | HTR2A (0.58) | MAPTHTR2AL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL7874386 | 0.87 | HTR2A (0.58) | MAPTHTR2AL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL29104758 | 0.87 | RORA (0.47) | MAPTHTR2AKDM4EALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8283855-B2 | Method for synthesis of anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-10-09 | — | — | US | claimed |
| US-20110172441-A1 | METHOD FOR SYNTHESIS OF ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-07-14 | — | — | US | claimed |
| EP-2110369-A1 | Method of synthesizing 9-aryl-10-iodoanthracene derivative and light-emitting material | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-10-21 | — | — | EP | claimed |
| US-20090247795-A1 | Method of Synthesizing 9-Aryl-10-Iodoanthracene Derivative and Light-Emitting Material | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-10-01 | — | — | US | claimed |
| CN-101506163-A | Method for synthesizing anthracene derivative and anthracene derivative, light emitting element, light emitting device, electronic device | SEMICONDUCTOR ENERGY LAB (JP) | 2009-08-12 | — | — | CN | claimed |
| US-20080107918-A1 | METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-05-08 | — | — | US | claimed |
| WO-2008026614-A1 | METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-03-06 | — | — | WO | claimed |
| CN-114956933-A | Marker containing isotope oxygen atom and preparation method and application thereof | 清华大学 | 2022-08-30 | — | — | CN | disclosed |
| CN-111517902-B | Aerobic oxidation system containing sulfinic acid, sulfonic acid or derivatives thereof and photo-oxidation promoting method thereof | 清华大学 | 2022-06-14 | — | — | CN | disclosed |
| CN-111517902-A | Aerobic oxidation system containing sulfinic acid, sulfonic acid or derivatives thereof and photo-oxidation promoting method thereof | 清华大学 | 2020-08-11 | — | — | CN | disclosed |
| WO-2020155595-A1 | AEROBIC OXIDATION SYSTEM CONTAINING SULFINIC ACID, SULFONIC ACID OR DERIVATIVES THEREOF AND PHOTOCATALYTIC OXIDATION METHOD THEREFOR | 清华大学 | 2020-08-06 | — | — | WO | disclosed |
| CN-109071960-A | Silicon-containing heterocyclic compound and matting agent | 富士胶片和光纯药株式会社 | 2018-12-21 | — | — | CN | disclosed |
| EP-2066629-B1 | ANTHRACENE DERIVATIVE, AND LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC DEVICE USING THE ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LAB (JP) | 2017-05-17 | — | — | EP | disclosed |
| US-20070075632-A1 | Anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-04-05 | — | — | US | disclosed |
| WO-2007029530-A1 | ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-03-15 | — | — | WO | disclosed |
| WO-2007013537-A1 | ANTHRACENE DERIVATIVE, MATERIAL FOR LIGHT EMITTING ELEMENT, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC APPLIANCE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-02-01 | — | — | WO | disclosed |
| WO-2005110950-A1 | SYNTHESIS OF UNSYMMETRIC ANTHRACENE COMPOUNDS | EASTMAN KODAK COMPANY (US) | 2005-11-24 | — | — | WO | disclosed |
| US-20050245752-A1 | Synthesis of unsymmetric anthracene compounds | EASTMAN KODAK COMPANY | 2005-11-03 | — | — | US | disclosed |
| JP-2005015403-A | PREPARATION METHOD OF ARYLANTHRACENE COMPOUND | GIFU UNIV | 2005-01-20 | — | — | JP | disclosed |
| US-4131646-A | Preparation of hydrogen peroxide from dihydroanthracene hydroperoxides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172441-A1 | METHOD FOR SYNTHESIS OF ANTHRACENE DERIVATIVE | CYP1A1, AHR, CYP2C9 | MAPT 4827/4885HTR2A 2789/4885L3MBTL1 4147/4885 |
| US-20080107918-A1 | METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE | ALAD, CYP2C9, CYP1A1 | MAPT 4161/4885HTR2A 4271/4885L3MBTL1 3456/4885 |
| US-20070075632-A1 | Anthracene derivative | CRY2, XPOT, CRY1 | MAPT 3436/4885HTR2A 3053/4885L3MBTL1 2830/4885 |
| US-20090247795-A1 | Method of Synthesizing 9-Aryl-10-Iodoanthracene Derivative and Light-Emitting Material | NISCH, TPO, INTS9 | MAPT 2573/4885HTR2A 101/4885L3MBTL1 3674/4885 |
| US-20050245752-A1 | Synthesis of unsymmetric anthracene compounds | PFAS, ACSL3, AFF2 | MAPT 4846/4885HTR2A 2931/4885L3MBTL1 4049/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.